Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Gilles Devouassoux"'
Autor:
José María Echave-Sustaeta María-Tomé, Peter Lange, David A. Lomas, Fernando J. Martinez, Holly Quasny, MeiLan K. Han, C. Elaine Jones, Mark T. Dransfield, Nicola A. Hanania, Arnaud Bourdin, Robert A. Wise, L. Saïl, Henrik Watz, David M.G. Halpin, Gilles Devouassoux, Gerard J. Criner, Byron Thomashow, Neil R.W. Martin, Ravi Kalhan, Thomas Siler, David A. Lipson, Dave Singh, Sally Lettis
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Chronic Obstr Pulm Dis
Universidad Europea (UEM)
Chronic Obstr Pulm Dis
Background: The InforMing the Pathway of COPD Treatment (IMPACT) trial demonstrated lower moderate/ severe exacerbation rates with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI or UMEC/VI in patients with chronic obstructive p
Autor:
Christos Chouaid, Gaëlle Nachbaur, Manon Belhassen, Eric Van Ganse, F. Dalon, L. Saïl, Camille Correia Da Silva, Gilles Devouassoux, F. Jacoud
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:2905-2915
Purpose This study assessed therapy persistence in patients with chronic obstructive pulmonary disease (COPD) in France, and the impact of non-persistence on exacerbations and described COPD-related healthcare resource use (HRU). Methods Patients age
Autor:
W. Chumbi-Flores, Gilles Devouassoux, C.-M. Gaillard, L. Kiakouama-Maleka, F. Craighero, L. Gaillot-Durand
Publikováno v:
Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36, pp.902-905. ⟨10.1016/j.rmr.2019.05.040⟩
Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36, pp.902-905. ⟨10.1016/j.rmr.2019.05.040⟩
Tyrosine kinase inhibitors are now major actors for the treatment of non-small-cell metastatic lung cancers where ROS 1 gene rearrangement is present. Because of the rapid development of these new therapies, developing information about their monitor
Autor:
Mark C. Liu, Jay Azmi, Gilles Devouassoux, Steven G. Smith, Robert G. Price, Miguel Bergna, Dalal Mouneimne, Bradley E. Chipps, Dmitry V Galkin, Xavier Muñoz, Kenneth R. Chapman, Frank C. Albers
Publikováno v:
Scientia
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Respiratory Research
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Respiratory Research
Background The OSMO study assessed the efficacy of switching to mepolizumab in patients with severe eosinophilic asthma that was uncontrolled whilst receiving omalizumab. The objective of this analysis was to assess the proportion of patients achievi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8deb811de3f5f13f4f6b792bc5f97be
https://hdl.handle.net/11351/6793
https://hdl.handle.net/11351/6793
Autor:
Harrison, Tim W, Chanez, Pascal, Menzella, Francesco, Canonica, Giorgio Walter, Louis, Renaud, Cosio, Borja G, Lugogo, Njira L, Mohan, Arjun, Burden, Annie, McDermott, Lawrence, Garcia Gil, Esther, Zangrilli, James G, Wolfgang Pohl, Robert Voves, Maud Deschampheleire, Renaud Louis, Jean-Benoit Martinot, Rudi Peché, Kenneth Chapman, Amarjit Cheema, Delbert Dorscheid, J Mark FitzGerald, Remi Gagnon, William Patrick Killorn, Ronald Olivenstein, George Philteos, Clare Ramsey, J Douglass Rolf, Brandie Walker, Ole Hilberg, Tina Skjold, Ingrid Titlestad, Auli Hakulinen, Maritta Kilpeläinen, Michèle Ben Hayoun, Philippe Bonniaud, Arnaud Bourdin, Pascal Chanez, Frédéric De Blay, Gaëtan Deslee, Gilles Devouassoux, Alain Didier, Youcef Douadi, Stéphanie Fry, Gilles Garcia, Pierre-Olivier Girodet, Christophe Leroyer, Antoine Magnan, Guillaume Mahay, Cécilia Nocent, Christophe Pison, Pauline-Marie Roux, Camille Taillé, Juliana-Angelica Tiotiu, Ekkehard Beck, Margret Jandl, Christian Kaehler, Frank Kässner, Frank Koesters, Juliane Kronsbein, Thomas Schaum, Christian Schulz, Dirk Skowasch, Christian Taube, Tobias Welte, Andrés de Roux, Bianca Beghé, Francesco Blasi, Giorgio Walter Canonica, Giovanna Carpagnano, Cristiano Caruso, Angelo Guido Corsico, Elio Constantino, Nunzio Crimi, Piero Maestrelli, Francesco Menzella, Manlio Milanese, Alberto Papi, Girolamo Pelaia, Laura Pini, Pierachille Santus, Eleonora Savi, Nicola Scichilone, Gianenrico Senna, Giuseppe Spadaro, Adriano Vaghi, Steven Gans, Jurgen Hölters, B Langeveld, Willem Pieters, G H A Staaks, Ilonka van Veen, J W K van den Berg, Gunnar Einvik, Sverre Lehmann, Ismael Ali García, Carlos Almonacid, Irina Bobolea, Paloma Campo Mozo, Gustavo de Luiz, Christian Domingo Ribas, José María Echave-Sustaeta María-Tomé, Juan Luis García Rivero, Borja García-Cosío Piqueras, Ana Gómez-Bastero Fernández, Ruperto González Pérez, Aythamy Henríquez Santa, Carlos Martínez Rivera, Xavier Muñoz Gall, Jacinto Ramos, Jose Gregorio Soto Campos, Carmen Vidal Pan, Nikolai Stenfors, Alf Tunsäter, Ines Vinge, Rekha Chaudhuri, Timothy Harrison, Adel Mansur, Shuaib Nasser, Monica Nordstrom, Paul Pfeffer, Dinesh Saralaya, Philip Short, Arun Adlakha, Oral Alpan, Francis Averill, Anil Badhwar, Jose Bardelas, Barbara Baxter, George Bensch, William Berger, Jonathan Bernstein, Tracy Bridges, Ryan Brimeyer, William Calhoun, Edward Campbell, William Brett Cherry, Geoffrey Chupp, Lee Clore, John Cohn, Jeremy Cole, John Condemi, James Cury, Benjamin Davis, Samuel DeLeon, Luis Delacruz, Joseph Diaz, David Erb, Emeka Eziri, Faisal Fakih, Douglas Fiedler, David Fost, Stephen Fritz, Erika Gonzalez, Brad Goodman, Peter Gottlieb, Gregory Gottschlich, Richard Gower, Rizan Hajal, James Harris, Hengameh Heidarian-Raissy, Albrecht Heyder, David Hill, Fernando Holguin, Iftikhar Hussain, Jonathan Illowite, Joshua Jacobs, Mikell Jarratt, Harold Kaiser, Neil Kao, Ravindra Kashyap, David Kaufman, Edward Kent, Kenneth Kim, Ryan Klein, Monica Kraft, Ritsu Kono, Shahrukh Kureishy, Jeffrey Leflein, Mila Leong, Huamin Li, Robert Lin, Njira Lugogo, Michael Marcus, Diego Jose Maselli Caceres, Vinay Mehta, Curtis Mello, Mark Millard, Aaron Milstone, Arjun Mohan, Wendy Moore, Mark Moss, Nayla Mumneh, Thomas O'Brien, David Ostransky, Michael Palumbo, Purvi Parikh, Sudhir Parikh, Amit Patel, Guido Perez, Warren Pleskow, Bruce Prenner, Dileep Puppala, John Ramey, Joan Reibman, Ramon Reyes, Emory Robinette, Ileana Rodicio, Stephen Ryan, Sudhir Sekhsaria, Barry Sigal, Vinay Sikand, Weily Soong, Selwyn Spangenthal, Roy St John, Gary Steven, Vijay Subramaniam, Kaharu Sumino, Eric Sztejman, Ricardo A Tan, Tonny Tanus, Charles Thompson, Carl Thornblade, Manuel Villareal, Sally Wenzel, Heidi Zafra, Tomasz Ziedalski
Publikováno v:
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2021, 9 (3), pp.260-274. ⟨10.1016/S2213-2600(20)30414-8⟩
The Lancet. Respiratory medicine, Vol. 9, no. 3, p. 260-274 (2021)
The Lancet Respiratory Medicine, Elsevier, 2021, 9 (3), pp.260-274. ⟨10.1016/S2213-2600(20)30414-8⟩
The Lancet. Respiratory medicine, Vol. 9, no. 3, p. 260-274 (2021)
Background: ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and nasal polyposis symptoms. Methods: This phase 3b, randomised, dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7980c098e2b8b43a3561652584e4867
https://hal.univ-reims.fr/hal-03170335
https://hal.univ-reims.fr/hal-03170335
Autor:
Dmitry V Galkin, Bradley Chipps, Miguel Bergna, Dalal Mouneimne, Mark C. Liu, Frank C. Albers, Xavier Muñoz, Gilles Devouassoux, Jay Azmi, Kenneth R. Chapman, Robert Price
Publikováno v:
Allergy
Background Mepolizumab and omalizumab are treatments for distinct but overlapping severe asthma phenotypes. Objective To assess if patients eligible for both biologics but not optimally controlled with omalizumab experience improved asthma control wh
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 7:1858-1867
Background Changes in asthma care need to be documented at arrival of biotherapies. Objectives To characterize changes in asthma care and outcomes in patients with persistent asthma. Methods Repeated transversal analyses were conducted on a historica
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 29, Iss 1, Pp 1-8 (2019)
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine
Because of insufficient asthma control in many patients, the collaboration between stakeholders is regarded as a promising strategy to improve asthma outcomes. This study explored the perceptions of French adult asthma patients on their care pathway.
Autor:
S. Fry, Laurent Guilleminault, Marion Gouitaa, Khuder Alagha, Gilles Devouassoux, Arnaud Bourdin, Carey M. Suehs, Pascal Chanez, Laurie Pahus, Camille Taillé, Jérémy Charriot, Laura Mattei, Christophe Brousse
Publikováno v:
Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, 2021, 15, pp.175346662110497. ⟨10.1177/17534666211049735⟩
Therapeutic Advances in Respiratory Disease, SAGE Publishing, 2021, 15, pp.175346662110497. ⟨10.1177/17534666211049735⟩
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Therapeutic Advances in Respiratory Disease, 2021, 15, pp.175346662110497. ⟨10.1177/17534666211049735⟩
Therapeutic Advances in Respiratory Disease, SAGE Publishing, 2021, 15, pp.175346662110497. ⟨10.1177/17534666211049735⟩
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: Current practices for assessing response to anti-interleukin 5/R treatment in severe asthma patients are heterogeneous. The objective of this study was to achieve an expert consensus defining failure criteria for anti-interleukin 5/R trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb777b9e90fca597995892255103c1a8
https://hal.science/hal-03374389
https://hal.science/hal-03374389
Autor:
Pierre-Olivier Girodet, Gilles Devouassoux, Antoine Deschildre, Alain Didier, Mathieu Molimard, Cécile Chenivesse, Chantal Raherison, Camille Taillé, Gilles Garcia
Publikováno v:
Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, 2020, 37 (5), pp.427-432. ⟨10.1016/j.rmr.2020.03.005⟩
Revue des Maladies Respiratoires, Elsevier Masson, A paraître, 37 (5), pp.427-432. ⟨10.1016/j.rmr.2020.03.005⟩
Revue des Maladies Respiratoires, 2020, 37 (5), pp.427-432. ⟨10.1016/j.rmr.2020.03.005⟩
Revue des Maladies Respiratoires, Elsevier Masson, A paraître, 37 (5), pp.427-432. ⟨10.1016/j.rmr.2020.03.005⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6a3f632074a6e816243111d2dfaa2f
https://ut3-toulouseinp.hal.science/hal-03565604
https://ut3-toulouseinp.hal.science/hal-03565604